The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository

计划入组 60 人 · 首次发布于 2010 年 4 月 23 日

NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia

计划入组 21 人 · 首次发布于 2023 年 11 月 9 日

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

计划入组 6 人 · 首次发布于 2017 年 5 月 1 日

Mipomersen(Kynamro)

familial hypercholesterolemia program

VRX-LDLR

The Familial Hypercholesterolemia Foundation

United States

Madrigal Pharmaceuticals

United States

FUNDACION HIPERCOLESTEROLEMIA FAMILIAR

Spain

Homozygous Familial Hypercholesterolemia Treatment Market to Surge by 2034

FDA Approves Juxtapid for Pediatric Patients with Homozygous Familial Hypercholesterolemia

FDA Grants Rare Disease Evidence Principles Eligibility to Repair Biotechnologies' mRNA Therapy for Homozygous Familial Hypercholesterolemia